Novel Immunotherapeutics Summit January 25 - 26, 2016, San Diego, CA
We invite you to GTCbio's Novel Immunotherapeutics Summit, which takes
place on January 25 - 26, 2016 in San Diego, CA. The summit will bring
together our usual balance of industry and academia, so that delegates
have the unique opportunity to network with colleagues from different
sectors and gain a fresh perspective on the various topics below.
14th Cytokines & Inflammation
This conference has become an established meeting point for academic
scientists, industry clinical developers, and government researchers to
discuss complementary approaches in the field of cytokine biology. Some
focused topics we will discuss include developments in the therapeutic
application of cytokines and proposal of new targets, the complex
relationship between the immune system and microbes in the homeostasis
of mucosal tissues, novel means to modulate immune pathways to promote
anti-tumor activity, and many more.
8th Immunotherapeutics & Immunomonitoring
Leading experts from the scientific and clinical arenas and industry
will present novel findings and developments in the constantly-changing
area of immunological assays and procedures. They will also discuss
recent advances in immunotherapy as they relate to various immunotherapy
modalities, specific cancers, cell subsets, animal models, and tumor
microenvironment. Potential clinical feasibility and commercial
potential of the newest data obtained from leading biomedical research
laboratories will also be discussed.
4th Immunogenicity & Immunotoxicity
We will provide guests with a better understanding of the ongoing
research for tools to mitigate risks associated with the immunogenicity
of therapeutic proteins. Guests will get an up-to-date understanding of
the mechanisms and consequences of protein aggregation and insights on
how to prosecute state-of-the-art assessment of the clinical
immunogenicity of therapeutic proteins.
3rd Allergy, Asthma, & COPD
Our gathering is a forum for researchers in the field to share advances
in topics ranging from basic scientific research to biomarkers and
clinical development. We will take a look at diseases such as
eosinophilic esophagitis and atopic dermatitis, along with disorders
involving comorbidities like ACOS. Another area of interest includes
biomarkers for understanding phenotypes in allergic diseases. This
meeting is the ideal event for networking and discussion on progress
towards therapeutic potential in these disease areas.
Conference Dates: January 25 - 26, 2016
https://www.gtcbio.com/conferences/immunotherapeutics-summit-overview
| < Prev | Next > |
|---|
